Evidence map›Paper›PMID 26607595›Full record

ArticleExperimental hematology2016

Inefficient megakaryopoiesis in mouse hematopoietic stem-progenitor cells lacking T-bet.

Aki Furusawa, Kavitha Sadashivaiah, Zeba N Singh, Curt I Civin, Arnob Banerjee

Open access · greenAbstract read
In one paragraph

Article in Experimental hematology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. mTORC1 Promotes T-bet Phosphorylation To Regulate Th1 Differentiation.Journal of immunology (Baltimore, Md. : 1950) · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Aki FurusawaDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD; Program in Oncology, Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD; Center for Stem Cell Research and Regenerative Medicine, University of Maryland School of Medicine, Baltimore, MD.
Kavitha SadashivaiahDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD; Program in Oncology, Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD; Center for Stem Cell Research and Regenerative Medicine, University of Maryland School of Medicine, Baltimore, MD.
Zeba N SinghProgram in Oncology, Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD.
Curt I CivinProgram in Oncology, Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD; Center for Stem Cell Research and Regenerative Medicine, University of Maryland School of Medicine, Baltimore, MD; Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD; Department of Physiology, University of Maryland School of Medicine, Baltimore, MD.
Arnob BanerjeeDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MD; Program in Oncology, Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD; Center for Stem Cell Research and Regenerative Medicine, University of Maryland School of Medicine, Baltimore, MD. Electronic address: abanerjee@som.umaryland.edu.
U-M Rogel Cancer CenterUniversity of Maryland, Baltimore · US

Funding

UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANTP30CA134274 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI FEYRUZ VIRGILIA RASSOOL · 2008 to 2026
$51.0M
Transcriptional regulation of CD8+ T cell differentiationK08HL093027 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI BANERJEE, ARNOB · 2010 to 2014
$658k
NCI NIH HHS P30 CA134274NCI NIH HHS P30CA134274NHLBI NIH HHS K08 HL093027NHLBI NIH HHS K08HL93207
6 · The paper itself

Abstract

Differentiation of hematopoietic stem-progenitor cells (HSPCs) into mature blood lineages results from the translation of extracellular signals into changes in the expression levels of transcription factors controlling cell fate decisions. Multiple transcription factor families are known to be involved in hematopoiesis. Although the T-box transcription factor family is known to be involved in the differentiation of multiple tissues, and expression of T-bet, a T-box family transcription factor, has been observed in HSPCs, T-box family transcription factors do not have a described role in HSPC differentiation. In the current study, we address the functional consequences of T-bet expression in mouse HSPCs. T-bet protein levels differed among HSPC subsets, with highest levels observed in megakaryo-erythroid progenitor cells (MEPs), the common precursor to megakaryocytes and erythrocytes. HSPCs from T-bet-deficient mice exhibited a defect in megakaryocytic differentiation when cultured in the presence of thrombopoietin. In contrast, erythroid differentiation in culture in the presence of erythropoietin was not substantially altered in T-bet-deficient HSPCs. Differences observed with respect to megakaryocyte number and maturity, as assessed by level of expression of CD41 and CD61, and megakaryocyte ploidy, in T-bet-deficient HSPCs were not associated with altered proliferation or survival in culture. Gene expression micro-array analysis of MEPs from T-bet-deficient mice exhibited diminished expression of multiple genes associated with the megakaryocyte lineage. These data advance our understanding of the transcriptional regulation of megakaryopoiesis by supporting a new role for T-bet in the differentiation of MEPs into megakaryocytes.

Indexed as

Cell DifferentiationCell ProliferationAnimalsCell SurvivalErythrocytesHematopoietic Stem CellsIntegrin beta3MegakaryocytesMiceMice, Mutant StrainsPlatelet Membrane Glycoprotein IIbT-bet Transcription FactorT-Box Domain ProteinsIntegrin beta3Platelet Membrane Glycoprotein IIbT-bet Transcription FactorT-Box Domain Proteins

Identifiers

PMID26607595
PMCPMC4789076
OpenAlexW2180775997

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.